-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In February 2022, the European Association for Nuclear Medicine (EANM) published guidelines for the treatment of liver and metastatic liver cancer with intra-arterial radioactive compounds
.
Primary liver cancer is one of the most common cancers worldwide, yet only 10%-20% of patients can receive treatment
In February 2022, the European Association for Nuclear Medicine (EANM) published guidelines for the treatment of liver and metastatic liver cancer with intra-arterial radioactive compounds
.
Primary liver cancer is one of the most common cancers worldwide, yet only 10%-20% of patients can receive treatment
.
This article provides guidance on the procedures for the treatment of liver cancer and metastatic liver cancer with intra-arterial radioactive compounds
.
Guide leave a message here